[1]
“The use of SGLT2 to improve clinical outcome in patients with heart failure and chronic kidney disease: a systematic review”, Acervo Saúde, vol. 23, no. 2, p. e11571, Feb. 2023, doi: 10.25248/reas.e11571.2023.